Edwards, Medtronic heart valve systems prove worth in low-risk patients -studies [Reuters]
Medtronic plc. Ordinary Shares (MDT)
Last medtronic plc. ordinary shares earnings: 2/18 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investorrelations.medtronic.com
Company Research
Source: Reuters
Edwards, Medtronic heart valve systems prove worth in low-risk patients: studies (Reuters) - Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results presented on Saturday. Both companies already have approvals for their TAVR (transcatheter aortic valve replacement) systems for use in patients too frail to endure surgery and those deemed at intermediate risk. Approvals in low-risk patients would open up a large new population for the devices seen as vital growth drivers for the companies. An estimated 165,000 low-risk patients suffer from severe aortic stenosis each year in the United States, Western Europe and Japan, a condition that can lead to heart failure in as little as two years, Medtronic said. With TAVR, the replacement heart valve is threaded into place through an artery via c
Show less
Read more
Impact Snapshot
Event Time:
MDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDT alerts
High impacting Medtronic plc. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDT
News
- Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update [Yahoo! Finance]Yahoo! Finance
- Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis [Yahoo! Finance]Yahoo! Finance
- Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosisPR Newswire
- US Bariatric Surgery Market to Reach $1.09 Billion by 2029 Amidst Rising Obesity and Health Initiatives [Yahoo! Finance]Yahoo! Finance
- Healthcare Consumables Market Size Expected to Reach USD 219.12 Bn by 2033 [Yahoo! Finance]Yahoo! Finance
MDT
Earnings
- 2/20/24 - Miss
MDT
Sec Filings
- 3/7/24 - Form 4
- 2/27/24 - Form 10-Q
- 2/23/24 - Form 4
- MDT's page on the SEC website